Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

被引：0

作者：

Wyles, David ^{[1
]}

Weiland, Ola ^{[2
]}

Yao, Betty ^{[3
]}

Reindollar, Robert ^{[4
]}

Weilert, Frank ^{[5
]}

Dufour, Jean-Francois ^{[6
]}

Gordon, Stuart ^{[7
]}

Poordad, Fred ^{[8
]}

Stoehr, Albrecht ^{[9
]}

Brown, Ashley ^{[10
]}

Mauss, Stefan ^{[11
]}

Samanta, Suvajit ^{[3
]}

Pilot-Matias, Tami ^{[3
]}

Rodrigues, Lino, Jr. ^{[3
]}

Trinh, Roger ^{[3
]}

机构：

[1] Denver Hlth Med Ctr, Denver, CO USA

[2] Karolinska Univ Hosp Huddinge, Stockholm, Sweden

[3] AbbVie Inc, N Chicago, IL USA

[4] Piedmont HealthCare, Statesville, NC USA

[5] Waikato Hosp, Hamilton, New Zealand

[6] Inselspital Bern, Bern, Switzerland

[7] Henry Ford Hosp, Detroit, MI 48202 USA

[8] Univ Texas Hlth, Texas Liver Inst, San Antonio, TX USA

[9] IFI Studien & Projekte Gmbh, Hamburg, Germany

[10] Imperial Coll Healthcare NHS Trust, London, England

[11] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany

来源：

SWISS MEDICAL WEEKLY | 2018年 / 148卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：25S / 25S

页数：1

共 50 条

[21] Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C
Grover, Anupriya
Erlich, Deborah R.
AMERICAN FAMILY PHYSICIAN, 2018, 98 (10) : 601 - 602
[22] Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naive Patients With Hepatitis C Virus Infection
Zuckerman, Eli
Gutierrez, Julio A.
Dylla, Douglas E.
de Ledinghen, Victor
Muir, Andrew J.
Gschwantler, Michael
Puoti, Massimo
Caruntu, Florin
Slim, Jihad
Nevens, Frederik
Sigal, Samuel
Cohen, Stanley
Fredrick, Linda M.
dos Santos, Ana Gabriela Pires
Rodrigues, Lino, Jr.
Dillon, John F.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (11) : 2544 - +
[23] A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs
Yi, Shana
Truong, David
Conway, Brian
JOURNAL OF VIRUS ERADICATION, 2024, 10 (03)
[24] Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older
Komaki, Yuri
Ozono, Yoshinori
Nakamura, Kenichi
Iwakiri, Hisayoshi
Hasuike, Satoru
Sueta, Mitsue
Miike, Tadashi
Yamamoto, Shojiro
Uto, Hirofumi
Kusumoto, Kazunori
Ochiai, Toshimasa
Kato, Junya
Komada, Naoto
Kuroki, Kazuo
Eto, Toshiharu
Shigehira, Masafumi
Hirono, Shuichi
Nagata, Kenji
Kawakami, Hiroshi
BMC GASTROENTEROLOGY, 2022, 22 (01)
[25] Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the grand plan study
Conway, Brian
Truong, David
Rhee, Dorothy
Yamamoto, Leo
Sian, Priya
Parsons, Robyn
Jones, Lauren
Magel, Tianna
Wuerth, Kelli
JOURNAL OF HEPATOLOGY, 2020, 73 : S333 - S333
[26] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
Liu, Chen-Hua
Liu, Chun-Jen
Hung, Chien-Ching
Hsieh, Szu-Min
Su, Tung-Hung
Sun, Hsin-Yun
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
LIVER INTERNATIONAL, 2020, 40 (04) : 758 - 768
[27] Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital
Ruwayni, Ali A.
Alobary, Eman E.
Alyahya, Khalid M.
SAUDI MEDICAL JOURNAL, 2024, 45 (01) : 34 - 39
[28] Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study
Persico, Marcello
Aglitti, Andrea
Milella, Michele
Coppola, Carmine
Messina, Vincenzo
Claar, Ernesto
Gentile, Ivan
Sogari, Fernando
Pierri, Paola
Surace, Lorenzo A.
Morisco, Filomena
Tundo, Paolo
Brancaccio, Giuseppina
Serviddio, Gaetano
Gatti, Pietro
Termite, Antonio P.
Di Costanzo, Giovan G.
Caroleo, Benedetto
Cozzolongo, Raffaele
Coppola, Nicola
Longo, Annamaria
Fontanella, Luca
Federico, Alessandro
Rosato, Valerio
Terrenato, Irene
Masarone, Mario
LIVER INTERNATIONAL, 2019, 39 (10) : 1852 - 1859
[29] Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older
Yuri Komaki
Yoshinori Ozono
Kenichi Nakamura
Hisayoshi Iwakiri
Satoru Hasuike
Mitsue Sueta
Tadashi Miike
Shojiro Yamamoto
Hirofumi Uto
Kazunori Kusumoto
Toshimasa Ochiai
Junya Kato
Naoto Komada
Kazuo Kuroki
Toshiharu Eto
Masafumi Shigehira
Shuichi Hirono
Kenji Nagata
Hiroshi Kawakami
BMC Gastroenterology, 22
[30] Glecaprevir/Pibrentasvir for the Treatment of Patients with Chronic Hepatitis C Virus Infection: Updated Real-World Data from the German Hepatitis C-Registry
Wiegand, Johannes
Naumann, Uwe
Stoehr, Albrecht
Sick, Christoph
John, Christine
Teuber, Gerlinde
Schiffelholz, Willibold, Sr.
Mauss, Stefan
Lohmann, Kristina
Koenig, Bettina
Pangerl, Andreas
Simon, Karl-Georg
HEPATOLOGY, 2018, 68 : 364A - 364A

← 1 2 3 4 5 →